Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite MS

BACKGROUND: We explored the effect of teriflunomide on cortical gray matter (CGM) and whole brain (WB) atrophy in patients with clinically isolated syndrome (CIS) from the phase III TOPIC study and assessed the relationship between atrophy and risk of conversion to clinically definite MS (CDMS). MET...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ther Adv Neurol Disord
Главные авторы: Zivadinov, Robert, Dwyer, Michael G., Carl, Ellen, Poole, Elizabeth M., Cavalier, Steve, Briassouli, Paraskevi, Bergsland, Niels
Формат: Artigo
Язык:Inglês
Опубликовано: SAGE Publications 2020
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7672760/
https://ncbi.nlm.nih.gov/pubmed/33240397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286420970754
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы